European Archives - Page 48 of 1096 - European Medical Journal

Heather McArthur

Onc Now: Episode 12: The Future of Breast Cancer Immunotherapy

Heather McArthur, Associate Professor in the Department of Medicine at University of Texas, UT Southwestern Medical Center, discusses recent advancements in breast cancer immunotherapy, and the future of personalised care.

AI System Shows Promise in Detecting Breast Cancer via Abbreviated MRI: ECR 2025

The system, which analyses high-risk screening and diagnostic MRI scans, was tested on datasets from five hospital groups across different countries.

Google’s AI Smartwatch Detects Cardiac Arrest with High Accuracy

Google researchers developed a smartwatch algorithm that detects cardiac arrest with high accuracy, potentially improving survival rates.

The word spotlight on a blue background

Spotlight: February 2025

From a historic vaccine approval to a $50bn investment reshaping US drug manufacturing, February brought major pharma news to the fore.

Sickle Cell Disease Therapies Remain Underused Despite Proven Benefits

Recent research highlights the significant underuse of disease-modifying therapies for sickle cell disease, despite their established benefits in reducing pain and preventing organ damage.

Genetic Links to High Type 2 Diabetes Risk in Asian Indian Families

New research uncovers explanation for higher rates of Type 2 diabetes in Asian Indian populations.

Oral Immunotherapy with Peanut Butter Boosts Allergy Tolerance in Children

Peanut oral immunotherapy using home-measured peanut butter significantly improves long-term desensitisation in children with high-threshold peanut allergy.

Does Enoxaparin Prevent Thrombosis After Liver Transplant?

These findings challenge existing practices in some institutions that administer prophylactic anticoagulation after liver transplantation.

New Study Shows Haemorrhagic Strokes Double Dementia Risk

Brain haemorrhages double dementia risk, urging regular cognitive screening for affected patients. New research highlights critical clinical implications.

Unveiling the Impact of ANCA Positivity on ILD Outcomes

Study reveals ANCA positivity in 22.4% of patients with ILD, with implications on survival.